Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
VIRthis companyVir Biotechnology, Inc.	$13.97	-1.91×	1.09×	12.18×	-1.73×	-733.1%	82.9%	-682.7%	-638.9%	-57.2%	-50.9%	-47.5%	0.24×	0.1×	0×	5.54×	0.0%	3	3.34	2	C
ABUSArbutus Biopharma Corp	$3.67	-28.29×	12.04×	65.44×	-27.47×	-163.1%	97.4%	-192.1%	-237.9%	-43.7%	-30.3%	-4.3%	0.05×	0.42×	-278.88×	15.73×	0.0%	5	28.57	4	A-
ASMBAssembly Biosciences, Inc.	$21.12	-61.84×	1.84×	5.27×	-54.31×	-382.4%	99.8%	-16.8%	-8.5%	-3.0%	-5.8%	-10.8%	0.01×	9.31×	0×	5.22×	0.0%	2	7.22	2	B-
AVIRAtea Pharmaceuticals, Inc.	$4.40	-1.84×	1.06×	0×	-1.19×	-75.3%	0.0%	0.0%	0.0%	-57.5%	-63.0%	-45.4%	0×	0.58×	0×	7.82×	0.0%	2	1.99	3	B-
BCRXBioCryst Pharmaceuticals, Inc.	$7.62	6.19×	-13.74×	1.87×	5.71×	-1611.4%	97.8%	39.0%	30.2%	-221.4%	105.2%	20.0%	-3.68×	1×	4.32×	2.06×	0.0%	5	-3.69	2	B-
COCPCocrystal Pharma, Inc.	$1.05	-1.26×	1.75×	0×	-0.65×	-55.3%	0.0%	0.0%	0.0%	-139.5%	-115.1%	-74.2%	0.24×	0.65×	0×	3.68×	0.0%	3	-108.13	1	C-
Peer median	—	-1.84×	1.75×	1.87×	-1.19×	-163.1%	97.4%	0.0%	0.0%	-57.5%	-30.3%	-10.8%	0.01×	0.65×	0×	5.22×	0.0%	3	1.99	2	—